About Diffusionpharma.com
diffusion pharmaceuticals inc. is an innovative biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to the areas where it is needed...
Read complete descriptionDiffusionpharma.com Email Format Analysis
The most widely used email format at Diffusionpharma.com is {f}{last}. Additionally, this format is used by approximately 76% of their employees.
Format Example:
Alternative Email Formats Used by Diffusionpharma.com
Moreover, Diffusionpharma.com also uses additional email patterns for different departments or roles:
In total, Diffusionpharma.com uses 3 different email format patterns. Therefore, understanding these variations helps ensure successful contact attempts.
Complete Email Format Breakdown
The following table shows all email formats used by Diffusionpharma.com employees. Furthermore, the percentage indicates how commonly each format is used within the organization.
Email Format Pattern | Example Address | Usage Percentage |
---|---|---|
{f}{last} | jsmith@diffusionpharma.com | 76% |
{first}.{last} | john.smith@diffusionpharma.com | 7% |
{first} | john@diffusionpharma.com | 7% |
How to Use Diffusionpharma.com Email Formats
- Identify the person's name: First, find the full name of the Diffusionpharma.com employee you want to contact.
- Apply the primary format: Next, use the most common format pattern ({f}{last}) to construct their email address.
- Verify before sending: Additionally, use email verification tools to confirm the address is valid and deliverable.
- Try alternative formats: Furthermore, if the primary format doesn't work, try other patterns shown in our analysis.
Email format data last updated: April 4th 2025, 07:42:18 pm
Moreover, we continuously monitor and update email format patterns to ensure accuracy.
Email Format Verification Tool
Test if your constructed email addresses match the verified patterns in our database. Additionally, our tool combines email verification with email discovery to ensure maximum accuracy.